Run-in Phase III Trial Design With Pharmacodynamics Predictive BiomarkersFANGXIN HONG; SIMON, Richard.Journal of the National Cancer Institute. 2013, Vol 105, Num 21, pp 1628-1633, issn 0027-8874, 6 p.Article

Incremental value in outcome prediction with gene expression―based signatures in diffuse large B-cell lymphomaFANGXIN HONG; KAHL, Brad S; GRAY, Robert et al.Blood. 2013, Vol 121, Num 1, pp 156-158, issn 0006-4971, 3 p.Article

RankProd : a bioconductor package for detecting differentially expressed genes in meta-analysisFANGXIN HONG; BREITLING, Rainer; MCENTEE, Connor W et al.Bioinformatics (Oxford. Print). 2006, Vol 22, Num 22, pp 2825-2827, issn 1367-4803, 3 p.Article

Gene Expression―Based Model Using Formalin-Fixed Paraffin-Embedded Biopsies Predicts Overall Survival in Advanced-Stage Classical Hodgkin LymphomaSCOTT, David W; CHAN, Fong Chun; WOOLCOCK, Bruce W et al.Journal of clinical oncology. 2013, Vol 31, Num 6, pp 692-700, issn 0732-183X, 9 p.Article

Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)GORDON, Leo I; FANGXIN HONG; ADVANI, Ranjana et al.Journal of clinical oncology. 2013, Vol 31, Num 6, pp 684-691, issn 0732-183X, 8 p.Article

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496EVENS, Andrew M; FANGXIN HONG; STIFF, Patrick J et al.British journal of haematology. 2013, Vol 161, Num 1, pp 76-86, issn 0007-1048, 11 p.Article

Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldenström MacroglobulinemiaGHOBRIAL, Irene M; FANGXIN HONG; SAM, Amy et al.Journal of clinical oncology. 2010, Vol 28, Num 8, pp 1422-1428, issn 0732-183X, 7 p.Article

CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumongenicity via c-maf-mediated interactions with bone marrow stromal cellsTAI, Yu-Tzu; SOYDAN, Ender; PODAR, Klaus et al.Blood. 2009, Vol 113, Num 18, pp 4309-4318, issn 0006-4971, 10 p.Article

Phase II Study of Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Immunochemotherapy Followed by Yttrium-90―Ibritumomab Tiuxetan in Untreated Mantle-Cell Lymphoma: Eastern Cooperative Oncology Group Study E1499SMITH, Mitchell R; HAILUN LI; GORDON, Leo et al.Journal of clinical oncology. 2012, Vol 30, Num 25, pp 3119-3126, issn 0732-183X, 8 p.Article

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trialTAN, King L; SCOTT, David W; STEIDL, Christian et al.Blood. 2012, Vol 120, Num 16, pp 3280-3287, issn 0006-4971, 8 p.Article

Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/ Refractory Waidenström's MacroglobulinemiaGHOBRIAL, Irene M; ROCCARO, Aldo; AZAB, Feda et al.Clinical cancer research (Print). 2010, Vol 16, Num 3, pp 1033-1041, issn 1078-0432, 9 p.Article

Endothelial stress products and coagulation markers in patients with multiple myeloma treated with lenalidomide plus dexamethasone: an observational studyROSOVSKY, Rachel; FANGXIN HONG; DOYLE, Mary et al.British journal of haematology. 2013, Vol 160, Num 3, pp 351-358, issn 0007-1048, 8 p.Article